10:00

Vaccine Adverse Events Reporting System (VAERS) background

Gina Mootrey, D.O., M.P.H., Senior Research Officer, Vaccine Safety Development Activity, Epidemiology and Surveillance Division, National Immunization Program, CDC

M. Miles Braun, M.D., M.P.H., Division of Epidemiology, Office of Biostatistics & Epidemiology, Center for Biologics Evaluation and Research, FDA

10:30

Break

10:45

Background on Anthrax Vaccine Expert Committee (AVEC)

Vito Caserta, M.D., M.P.H., National Vaccine Injury Compensation Program, Health Resources and Services Administration, DHHS

11:00

Sponsor overview of CDC research program

Benjamin Schwartz, M.D., Acting Director, Epidemiology & Surveillance Division, National Immunization Program, CDC

Michael M. McNeil, M.D., M.P.H., Chief, Anthrax Vaccine Safety Activity, Epidemiology & Surveillance Division, National Immunization Program

Kristine Sheedy, Ph.D., Health Communication Specialist, Vaccine Safety Development Activity, Epidemiology & Surveillance Division, National Immunization Program

Gina Mootrey, D.O., M.P.H., Senior Research Officer, Vaccine Safety Development Activity, Epidemiology & Surveillance Division, National Immunization Program

12:15 p.m.

Lunch

1:15

Sponsor overview of CDC research program, continued

Bradley A. Perkins, M.D., National Center for Infectious Diseases, CDC

2:00

Adjourn

Meeting II February 8, 2001

The Foundry Building 1055 Thomas Jefferson Street, NW Washington, DC

Agenda

Open Session

9:00 a.m.

Welcome, introductory remarks, and introductions by committee members and meeting attendees

Philip Brachman, M.D., Chairman, Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program

9:15

Review of charge

Philip Brachman, M.D.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement